| Dispensed a non-steroidal anti-inflammatory drug without urate-lowering therapy |
This measure shows the percentage of people with identified gout who were dispensed funded non-steroidal anti-inflammatory drugs (NSAIDs) but not dispensed urate-lowering therapy. While it is not known whether it was gout that led to an NSAID being dispensed, high rates of NSAID dispensing without urate-lowering therapy use may reflect people using NSAIDs to manage their acute gout flares. International best practice indicates that people experiencing frequent gout flares (two or more per year) should be offered long-term urate-lowering therapy. Large variation may reflect patient preference and/or variable clinical practice. |
National Minimum Dataset (NMDS), Pharmaceutical Collection (PHARMS), PHO Enrolment Collection, Mortality Collection, NZ Cancer Registry, Ministry of Health, National Population Projection - Stats NZ |
Health Quality & Safety Commission | Te Tāhū Hauora |
|
| Dispensed a non-steroidal anti-inflammatory drug |
This measure shows the percentage of people with identified gout who were dispensed funded non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs are often the first line of treatment for acute gout flares and some can be purchased from a pharmacy without a prescription. Although NSAIDs are effective at treating acute gout flares, these medicines have considerable side effects including kidney injury and peptic ulcer disease. |
National Minimum Dataset (NMDS), Pharmaceutical Collection (PHARMS), PHO Enrolment Collection, Mortality Collection, NZ Cancer Registry, Ministry of Health, National Population Projection - Stats NZ |
Health Quality & Safety Commission | Te Tāhū Hauora |
|
| Prevalence of diabetes |
This indicator shows the number and percent of the PHO enrolled New Zealand population recorded as having diabetes in the VDR. |
PHO Enrolment Collection, Virtual Diabetes Register (VDR) |
Health Quality & Safety Commission | Te Tāhū Hauora |
June 2024 |
| People not dispensed ICS regularly in the year after admission |
This indicator shows the number and percent of people aged 5 –44 years who were not regularly dispensed ICS in the four quarters after discharge for an admission with a primary diagnosis of asthma. Regular dispensing was defined as dispensing in two or more quarters in the year post discharge. This was calculated using the date of discharge and dividing the following 365 days into four quarters. |
National Minimum Dataset (NMDS), Pharmaceutical Collection (PHARMS), PHO Enrolment Collection |
Health Quality & Safety Commission | Te Tāhū Hauora |
September 2025 |
| Children admitted to hospital one or more times with a primary diagnosis of asthma or wheeze |
This measure gives the rate of children under 12 years who were admitted to hospital with asthma and wheeze as the primary diagnosis per 1,000 children. |
National Minimum Dataset (NMDS), PHO Enrolment Collection |
Health Quality & Safety Commission | Te Tāhū Hauora |
September 2025 |
| People with at least two hospital admissions within 90 days of each other with a primary diagnosis of asthma (or wheeze in children) |
This indicator shows the number and percent of people with at least two admissions within 90 days of each other. ED admissions meeting the three-hour rule are included in this indicator. |
National Minimum Dataset (NMDS), PHO Enrolment Collection |
Health Quality & Safety Commission | Te Tāhū Hauora |
September 2025 |
| People in ARC dispensed an antibiotic specifically indicated for UTIs, rate per 100 |
This measure details the rate per 100 of people listed in ARC dispensed an antibiotic specifically indicated for urinary tract infections (UTIs). Nitrofurantoin or trimethoprim are recommended as first-line treatment for UTIs. Norfloxacin is second-line treatment. The rationale for this measure is to explore the use of antibiotics for UTIs, with a view identifying whether there are areas of high use of these antibiotics. |
Pharmaceutical Collection (PHARMS), PHO Enrolment Collection, Ministry of Health |
Health Quality & Safety Commission | Te Tāhū Hauora |
|
| People dispensed an antibiotic specifically indicated for urinary tract infections, rate per 100 |
This measure details the rate per 100 of people dispensed an antibiotic specifically indicated for urinary tract infections (UTIs). Nitrofurantoin or trimethoprim are recommended as first-line treatment for UTIs. Norfloxacin is second-line treatment. The rationale for this measure is to explore the use of antibiotics for UTIs, with a view to identifying whether there are areas of high use of these antibiotics. |
Pharmaceutical Collection (PHARMS), PHO Enrolment Collection, Ministry of Health |
Health Quality & Safety Commission | Te Tāhū Hauora |
|
| People dispensed a broad-spectrum penicillin as a percent of all people dispensed a penicillin |
This measure details the number of people dispensed a broad-spectrum penicillin as a percentage of all people dispensed a penicillin. Broad-spectrum antibiotics are associated with antimicrobial resistance and are generally recommended only for certain indications. The other penicillins are classed as narrow spectrum. This measure calculates amoxicillin or amoxicillin with clavulanic acid use as a percent of total penicillin dispensing. Wide regional variation in the use of amoxicillin or amoxicillin with clavulanic acid might highlight areas for improvement. |
Pharmaceutical Collection (PHARMS), PHO Enrolment Collection, Ministry of Health |
Health Quality & Safety Commission | Te Tāhū Hauora |
|
| Seasonal variation in community systemic antibiotic dispensing, percent |
This measure shows the percentage of seasonal variation in community systemic antibiotic dispensing. While bacterial infections increase during winter, increased prescribing in winter may suggest antibiotics are also being used to treat viral respiratory infections. This may represent an opportunity to optimise antibiotic use. |
Pharmaceutical Collection (PHARMS), PHO Enrolment Collection, Ministry of Health, New Zealand Resident Population - Stats NZ |
Health Quality & Safety Commission | Te Tāhū Hauora |
|